ENIGMA Center for Worldwide Medicine, Imaging & Genomics
Project Number5U54EB020403-05
Former Number1U54HG008023-01
Contact PI/Project LeaderTHOMPSON, PAUL M
Awardee OrganizationUNIVERSITY OF SOUTHERN CALIFORNIA
Description
Abstract Text
DESCRIPTION (provided by applicant): The ENIGMA Center for Worldwide Medicine, Imaging and Genomics is an unprecedented global effort bringing together 287 scientists and all their vast biomedical datasets, to work on 9 major human brain diseases: schizophrenia, bipolar disorder, major depression, ADHD, OCD, autism, 22q deletion syndrome, HIV/AIDS and addictions. ENIGMA integrates images, genomes, connectomes and biomarkers on an unprecedented scale, with new kinds of computation for integration, clustering, and learning from complex biodata types. ENIGMA, founded in 2009, performed the largest brain imaging studies in history (N>26,000 subjects; Stein +207 authors, Nature Genetics, 2012) screening genomes and images at 125 institutions in 20 countries. Responding to the BD2K RFA, ENIGMA'S Working Groups target key programmatic goals of BD2K funders across the NIH, including NIMH, NIBIB, NICHD, NIA, NINDS, NIDA, NIAAA, NHGRI and FIC. ENIGMA creates novel computational algorithms and a new model for Consortium Science to revolutionize the way Big Data is handled, shared and optimized. We unleash the power of sparse machine learning, and high dimensional combinatorics, to cluster and inter-relate genomes, connectomes, and multimodal brain images to discover diagnostic and prognostic markers. The sheer computational power and unprecedented collaboration advances distributed computation on Big Data leveraging US and non-US infrastructure, talents and data. Our projects will better identify factors that resist and promote brain disease, that help diagnosis and prognosis, and identify new mechanisms and drug targets. Our Data Science Research Cores create new algorithms to handle Big Data from (1) Imaging Genomics, (2) Connectomics, and (3) Machine Learning & Clinical Prediction. Led by world leaders in the field who developed major software packages (e.g., Jieping Ye/SLEP), we prioritize trillions of computations for gene-image clustering, distributed multi-task machine learning, and new approaches to screen brain connections based on the Partition Problem in mathematics. Our ENIGMA Training Program offers a world class Summer School coordinated with other BD2K Centers, worldwide scientific exchanges. Challenge-based Workshops and hackathons to stimulate innovation, and Web Portals to disseminate tools and engage scientists in Big Data science.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: The ENIGMA Center for Worldwide Medicine, Imaging and Genomics is an unprecedented global effort uniting 287 scientists from 125 institutions and all their vast biomedical data, to work on 9 major human brain diseases: schizophrenia, bipolar disorder, major depression, ADHD, OCD, autism, 22q deletion syndrome, HIV/AIDS and addictions. ENIGMA integrates images from multiple modalities, genomes, connectomes and biomarkers on an unimaginable scale, with new computations to integrate, cluster, and learn from complex biodata types.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Acquired Immunodeficiency SyndromeAlgorithmsAttention deficit hyperactivity disorderAutistic DisorderBig DataBig Data to KnowledgeBiological MarkersBipolar DisorderBrainBrain DiseasesBrain imagingClinicalCollaborationsCombinatoricsComplexComputational algorithmComputer softwareCountryDataData ScienceData SetDiagnosisDiseaseDrug TargetingEducational workshopGenesGeneticGenetic studyGenomeGenomicsGoalsHIVHumanImageInstitutionJointsLearningMachine LearningMajor Depressive DisorderMathematicsMedicineModalityModelingNational Human Genome Research InstituteNational Institute of Biomedical Imaging and BioengineeringNational Institute of Child Health and Human DevelopmentNational Institute of Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNatureObsessive-Compulsive DisorderPrognostic MarkerRecording of previous eventsResearchResearch InfrastructureSchizophreniaSchoolsScienceScientistTalentsTrainingTraining ProgramsUnited States National Institutes of HealthWorkaddictionbasechromosome 22q deletion syndromecomputer scienceconnectomediagnostic biomarkerhackathonhigh dimensionalityimaging studyinnovationmultidisciplinarymultimodalitymultitaskneuroimagingnovelnovel strategiesorganizational structureoutcome forecastpublic health relevancescreeningsuccesstoolweb portalworking group
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
396
DUNS Number
072933393
UEI
G88KLJR3KYT5
Project Start Date
29-September-2014
Project End Date
30-September-2020
Budget Start Date
01-June-2018
Budget End Date
30-September-2020
Project Funding Information for 2018
Total Funding
$790,391
Direct Costs
$1,253,473
Indirect Costs
$201,494
Year
Funding IC
FY Total Cost by IC
2018
National Cancer Institute
$790,391
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U54EB020403-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54EB020403-05
Patents
No Patents information available for 5U54EB020403-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54EB020403-05
Clinical Studies
No Clinical Studies information available for 5U54EB020403-05
News and More
Related News Releases
No news release information available for 5U54EB020403-05
History
No Historical information available for 5U54EB020403-05
Similar Projects
No Similar Projects information available for 5U54EB020403-05